Plan B Switch Decision Deadline Postponed To May
This article was originally published in The Tan Sheet
Executive Summary
An FDA decision on the Rx-to-OTC switch of emergency contraceptive Plan B (levonorgestrel .75 mg) has been pushed back from February 20 to May 20
You may also be interested in...
Plan B Decision Expected In Coming Weeks – Barr CEO
Barr Labs anticipates OTC approval of its Plan B emergency contraceptive "in the following weeks," according to CEO Bruce Downey
Plan B Decision Expected In Coming Weeks – Barr CEO
Barr Labs anticipates OTC approval of its Plan B emergency contraceptive "in the following weeks," according to CEO Bruce Downey
Plan B Decision Expected In Coming Weeks – Barr CEO
Barr Labs anticipates OTC approval of its Plan B emergency contraceptive "in the following weeks," according to CEO Bruce Downey